Re-Evaluate Alteplase Contraindications in Your Stroke Protocol
March 2016
You'll hear controversy about whether more patients should receive alteplase (Activase) for acute ischemic stroke.
Changes in labeling suggest broadening the scope of stroke patients who should get alteplase. But this is due to new rules designed to simplify labeling...not new evidence.
Now the Am Heart and Stroke Associations are weighing in...saying yes to using alteplase in more patients...but with a few cautions.
Get concise advice on drug therapy, plus unlimited access to CE
Hospital Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote